Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	PXT3003 Low Dose
Total, all-cause mortality	PXT3003 Intermediate Dose
Total, all-cause mortality	PXT3003 High Dose
Total, all-cause mortality	Placebo
Total, other adverse events	PXT3003 Low Dose	12	21
Total, other adverse events	PXT3003 Intermediate Dose	10	21
Total, other adverse events	PXT3003 High Dose	13	19
Total, other adverse events	Placebo	11	19
Total, serious adverse events	PXT3003 Low Dose	2	21
Total, serious adverse events	PXT3003 Intermediate Dose	0	21
Total, serious adverse events	PXT3003 High Dose	0	19
Total, serious adverse events	Placebo	0	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01401257/event-totals